about
The Skin as an Early Expression of Malignancies in the Neonatal Age: A Review of the Literature and a Case SeriesEpigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectivesMicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkersMicroenvironmental Targets in SarcomaFurin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse modelStructural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcomaCombined experience of six independent laboratories attempting to create an Ewing sarcoma mouse modelRhabdomyosarcoma in adolescent and young adult patients: current perspectives.CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheresEnhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.Rhabdomyosarcomas in aging A/J mice.Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomasRhabdomyosarcoma of the head and neck in childrenSRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiationChildhood rhabdomyosarcoma: recent advances and prospective views.CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive RhabdomyosarcomaThe role of microRNAs in skeletal muscle health and diseaseMicroRNAs in skeletal muscle biology and exercise adaptation.Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patientsDual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcomaPhosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma.Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.Childhood rhabdomyosarcoma: new insight on biology and treatment.Caveolin-1 in sarcomas: friend or foe?Caveolins in rhabdomyosarcomaFibroblast growth factors and their receptors in cancer.MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.Rhabdomyosarcomas: an overview on the experimental animal models.Perianal rhabdomyosarcoma presenting 21 months after hamartoma excision.Implications for the mammalian sialidases in the physiopathology of skeletal muscleA call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.microRNAs and Soft Tissue Sarcomas.LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcomaTargeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives.Pleomorphic rhabdomyosarcoma infiltrating thoracic spine in a 59-year-old female patient: Case reportCalcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcomaToo much AKT turns PAX3-FKHR dead: a prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma.New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling.Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.
P2860
Q26769681-3D3C5EE4-33E3-43FC-9578-3594828F17CEQ26999187-959F5CDD-412F-4345-B2BA-0E9161C010FDQ27006159-F61AB8C6-2890-4ED5-8F9F-87ABEAD558DCQ28081400-0BD60216-60A1-40BA-979A-5B49AD07E84FQ28473831-50E17BFE-FBF3-4FE1-9B0E-A90754508F03Q31121475-BE1BA461-CE26-46F7-98EF-40F6DEF32D67Q33798299-88CB1FBF-F80B-4F9D-B6BA-E95D64414DBEQ33800135-CDB8F01F-9939-48AF-8119-D02C48812D47Q33908271-8BB6093C-DF44-48C3-AF58-14946A8C7B9CQ33910609-6CC39195-3276-438C-9D0F-C948CF15C999Q33997217-0C8BC9C9-1F7B-4D15-9CA9-3187E9A07135Q35067979-5FAD277D-1A5C-4E21-A65B-6E690AEDA387Q35648994-F17DB0D8-8D1A-45AB-B1CB-D3812E2E49ADQ35828593-D58AB3FE-1221-4029-9961-D5F24CF6477BQ35847829-A774EAC9-C3BC-4876-B9AB-14E48AB6B060Q36093810-620D23BF-1D46-4696-9007-C35967D9AE4CQ36860334-2536C7EF-265D-4E8C-B5A9-377AB60A4EE8Q36902753-78A0F36F-AB7D-42FF-94A4-9936924064D5Q37094042-51B6EA55-04C1-47BC-B84C-462B526F5802Q37281508-2050CD56-A7C4-4013-9758-81EFBD9C0A96Q37381276-F2194E05-F4CE-46F5-BBDF-0B2F7E8BBB3EQ37464647-9D5DDF2F-BFC7-43DF-9A4B-AABD8BEC73ACQ37649642-2869DE44-D2A2-433C-B1DB-F0F53FF01F6BQ37785820-06DC34E7-E02E-4883-8E6D-7A966489F264Q37862525-3FD6E86F-DDAB-4CF5-B831-EDC1E8EBAF78Q37894860-7EF2814F-7814-4942-8074-278F372E621CQ37895306-39A7F25D-4D2C-4770-A1CD-F9B1C96B22A2Q37937737-1A9290EF-90D3-4C9F-A04C-2D27B1BDB3C5Q37973827-AB31E88E-13AA-441B-8E42-B2CEDC2E06E3Q37994561-4C558329-477D-4ADB-A069-2331B0CCE773Q38056789-55395D8F-C77F-4C78-AADB-249C81FB0211Q38083828-F0DD1B26-FBF0-4191-898F-2AFFC26EF498Q38667023-717F6295-89CE-4F6D-A54F-2A48D29E1664Q39103791-631E0341-FB48-4DEF-AE46-17119CB12C7BQ39767891-58D23F7A-CDA9-404A-B427-B3D1EFEE2549Q41111792-9B06F515-FF1C-46D8-A217-FC16083A033BQ41847776-2F295935-5113-4D25-8E77-BAB6F0951190Q43082946-C1FD385D-F918-436C-991F-78D9262DE224Q50804445-C3410B32-ADCF-4DEC-B1C3-7A5E6A0CF3C8Q52873956-87C55343-24A8-4B84-93DF-AF3A91273A31
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Molecular and cellular biology of rhabdomyosarcoma.
@en
Molecular and cellular biology of rhabdomyosarcoma.
@nl
type
label
Molecular and cellular biology of rhabdomyosarcoma.
@en
Molecular and cellular biology of rhabdomyosarcoma.
@nl
prefLabel
Molecular and cellular biology of rhabdomyosarcoma.
@en
Molecular and cellular biology of rhabdomyosarcoma.
@nl
P2860
P50
P356
P1433
P1476
Molecular and cellular biology of rhabdomyosarcoma
@en
P2093
Carla De Giovanni
Giordano Nicoletti
P2860
P304
P356
10.2217/FON.09.97
P407
P577
2009-11-01T00:00:00Z